Ana López-Machado

2.5k total citations · 1 hit paper
12 papers, 1.8k citations indexed

About

Ana López-Machado is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Ana López-Machado has authored 12 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Ana López-Machado's work include Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Pediatric health and respiratory diseases (2 papers). Ana López-Machado is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Pediatric health and respiratory diseases (2 papers). Ana López-Machado collaborates with scholars based in Spain, Portugal and Italy. Ana López-Machado's co-authors include Eliana B. Souto, Elena Sánchez‐López, María L. García, Marta Espina, Amanda Cano, Miren Ettcheto, Antoni Camins, Amélia M. Silva, Antonello Santini and Ruth Galindo and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Ana López-Machado

12 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview

2020 1.0k citations Elena Sánchez‐López, Daniela Gomes et al. Nanomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana López-Machado Spain	11	645	422	371	317	265	12	1.8k
Sabya Sachi Das India	21	497 0.8×	575 1.4×	494 1.3×	365 1.2×	189 0.7×	44	1.9k
João Augusto Oshiro Brazil	17	436 0.7×	361 0.9×	349 0.9×	228 0.7×	261 1.0×	68	1.4k
Dinesh Dhamecha India	22	475 0.7×	455 1.1×	371 1.0×	248 0.8×	437 1.6×	44	1.6k
Magdalena Stevanović Serbia	20	470 0.7×	474 1.1×	381 1.0×	303 1.0×	161 0.6×	45	1.6k
Md Saquib Hasnain India	23	608 0.9×	357 0.8×	263 0.7×	216 0.7×	471 1.8×	68	1.8k
Neha Gulati India	13	414 0.6×	323 0.8×	455 1.2×	300 0.9×	476 1.8×	34	1.6k
Ghobad Mohammadi Iran	24	361 0.6×	284 0.7×	432 1.2×	285 0.9×	832 3.1×	69	1.7k
Munazza Ijaz Pakistan	25	254 0.4×	395 0.9×	390 1.1×	304 1.0×	507 1.9×	102	1.8k
Mas Jaffri Masarudin Malaysia	25	510 0.8×	445 1.1×	531 1.4×	534 1.7×	294 1.1×	60	1.9k
Simona Sapino Italy	24	336 0.5×	268 0.6×	477 1.3×	352 1.1×	470 1.8×	69	1.7k

Countries citing papers authored by Ana López-Machado

Since Specialization

Citations

This map shows the geographic impact of Ana López-Machado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana López-Machado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana López-Machado more than expected).

Fields of papers citing papers by Ana López-Machado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana López-Machado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana López-Machado. The network helps show where Ana López-Machado may publish in the future.

Co-authorship network of co-authors of Ana López-Machado

This figure shows the co-authorship network connecting the top 25 collaborators of Ana López-Machado. A scholar is included among the top collaborators of Ana López-Machado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana López-Machado. Ana López-Machado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Marqués, Ana M., Mireia Mallandrich, Lyda Halbaut, et al.. (2023). Colloidal hydrogel systems of thymol-loaded PLGA nanoparticles designed for acne treatment. Colloids and Surfaces B Biointerfaces. 234. 113678–113678. 6 indexed citations

López-Machado, Ana, Natalia Díaz‐Garrido, Amanda Cano, et al.. (2021). Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics. 13(10). 1698–1698. 55 indexed citations

López-Machado, Ana, Natalia Díaz‐Garrido, Amanda Cano, et al.. (2021). Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes. International Journal of Pharmaceutics. 609. 121188–121188. 31 indexed citations

Sánchez‐López, Elena, Daniela Gomes, Gerard Esteruelas, et al.. (2020). Metal-Based Nanoparticles as Antimicrobial Agents: An Overview. Nanomaterials. 10(2). 292–292. 1020 indexed citations breakdown →

Cano, Amanda, Miren Ettcheto, Marta Espina, et al.. (2020). State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections. Journal of Nanobiotechnology. 18(1). 156–156. 57 indexed citations

López-Machado, Ana, et al.. (2020). Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges. Current Pharmaceutical Design. 26(12). 1235–1250. 15 indexed citations

Cano, Amanda, Elena Sánchez‐López, Miren Ettcheto, et al.. (2020). Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases. Nanomedicine. 15(12). 1239–1261. 83 indexed citations

Souto, Selma B., Elena Sánchez‐López, Ana López-Machado, et al.. (2019). Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I. Pharmaceuticals. 12(4). 152–152. 127 indexed citations

Souto, Eliana B., João Dias-Ferreira, Elena Sánchez‐López, et al.. (2019). Trends in Atopic Dermatitis—From Standard Pharmacotherapy to Novel Drug Delivery Systems. International Journal of Molecular Sciences. 20(22). 5659–5659. 58 indexed citations

10.

Souto, Eliana B., João Dias-Ferreira, Ana López-Machado, et al.. (2019). Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents. Pharmaceutics. 11(9). 460–460. 140 indexed citations

11.

Souto, Selma B., Elena Sánchez‐López, Ana López-Machado, et al.. (2019). Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II. Journal of Clinical Medicine. 8(9). 1332–1332. 53 indexed citations

12.

Sánchez‐López, Elena, João Dias-Ferreira, Ana López-Machado, et al.. (2019). Current Applications of Nanoemulsions in Cancer Therapeutics. Nanomaterials. 9(6). 821–821. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact